Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Return on Equity (ROE)
since 2005

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Abiomed Inc., ROE, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).

1 US$ in thousands

The financial data reveals significant fluctuations in net income over the examined periods. Initially, there are substantial losses from 2005 through 2011, peaking in magnitude around 2006 and 2008. Starting in 2012, the company transitions into profitability, with net income showing consistent positive growth and reaching a pronounced peak in 2019. The highest net income value occurs in 2019, followed by a decline in the subsequent years, though income remains positive through 2022.

Stockholders’ equity shows a steady and strong upward trend throughout the period. From an initial figure of approximately 56 million USD in 2005, it grows consistently nearly every year, reaching over 1.5 billion USD by 2022. This continuous increase suggests ongoing capital accumulation and retained earnings, reflecting an improving financial foundation.

The Return on Equity (ROE) metric exhibits high volatility aligned with the net income trends. From significantly negative percentages in the early years, indicative of losses, ROE gradually improves, turning positive starting in 2012. Following this, the ROE trend generally ascends, reaching a peak in 2019 at 27.65%, signaling efficient utilization of shareholders' equity during that year. The subsequent years show a decline but maintain positive values, indicating sustained profitability albeit with reduced efficiency compared to the peak year.

Net Income (Loss)
Substantial losses in initial years, transitioning to profitability post-2011 with a peak in 2019, followed by a decrease but positive income in later years.
Stockholders’ Equity
Continuous growth across all years, indicating strengthening capital structure and accumulation of retained earnings.
Return on Equity (ROE)
Negative in early years due to losses, turning positive from 2012 onward with a peak efficiency in 2019, followed by moderate declines while remaining positive.

Comparison to Competitors

Abiomed Inc., ROE, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).


Comparison to Sector (Health Care Equipment & Services)

Abiomed Inc., ROE, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).


Comparison to Industry (Health Care)